» Articles » PMID: 33992051

An Updated Review of the Cross-talk Between MicroRNAs and Epigenetic Factors in Cancers

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2021 May 16
PMID 33992051
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Growing evidence indicates that miRs have critical activities in adjusting cellular processes, e.g., cell death, proliferation, and cell-cycle.

Introduction: This study aimed to provide a concise review of the recent findings regarding tumoral miRs and the cross-talk between miRs and epigenetic factors.

Results: Like the protein-coding genes, the expression levels of miRs are mediated by various transcriptional networks. Indeed, the expression of miRs could be epigenetically modulated by DNA methylation factors and histone modifiers. Furthermore, miRs can suppress critical factors, which mediate epigenetic modifications. Besides, miRs have been implicated in cancer development, metastasis, and chemo-resistance. The aberrant expression of miRs and dysregulated modulatory circuits between miRs and epigenetic factors participate in tumor progression.

Conclusion: Identifying tumoral miRs can provide ample opportunity to overcome chemo- resistance and bring a forefront treatment for affected patients.

Citing Articles

MicroRNA networks in prolactinoma tumorigenesis: a scoping review.

Rad S, Nejadi Orang F, Shadbad M Cancer Cell Int. 2024; 24(1):418.

PMID: 39702128 PMC: 11660578. DOI: 10.1186/s12935-024-03529-5.


hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway: and study.

Shadbad M, Baradaran B Oncol Res. 2024; 32(12):1949-1958.

PMID: 39574474 PMC: 11576920. DOI: 10.32604/or.2024.051569.


Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets.

Nejadi Orang F, Shadbad M Cell Death Dis. 2024; 15(5):357.

PMID: 38778030 PMC: 11111666. DOI: 10.1038/s41419-024-06732-4.


hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study.

Shadbad M, Baghbanzadeh A, Baradaran B EXCLI J. 2024; 23:384-400.

PMID: 38655096 PMC: 11036064. DOI: 10.17179/excli2023-6404.


HSV1 microRNAs in glioblastoma development: an in silico study.

Shadbad M, Hemmat N, Abdoli Shadbad M, Brunetti O, Silvestris N, Baradaran B Sci Rep. 2024; 14(1):27.

PMID: 38167429 PMC: 10761845. DOI: 10.1038/s41598-023-45249-2.